An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.
One common issue is hyperparathyroidism, where one or more parathyroid glands become overactive, producing excessive PTH and leading to high blood calcium levels. This can cause symptoms like ...